Thus, our results are rather limited to a specific type of leukemia and our data imply that SK/IK channel inhibitors could be used to slow down the proliferation and spreading of CML K562 cells that express functionally active SK2, SK3 and IK channels in the plasma membrane. This evidence concerns the gene KCNN1 and leukemia.